[⁶⁸Ga]Ga-FAP-2286-Synthesis, Quality Control and Comparison with [¹⁸F]FDG PET/CT in a Patient with Suspected Cholangiocellular Carcinoma

• Główni autorzy: Anton Amadeus Hörmann (Autor), Gregor Schweighofer-Zwink (Autor), Gundula Rendl (Autor), Kristina Türk (Autor), Samuel Nadeje (Autor), Kristina Haas (Autor), Theresa Jung (Autor), Ursula Huber-Schönauer (Autor), Lukas Hehenwarter (Autor), Mohsen Beheshti (Autor), Christian Pirich (Autor)
• Format: Książka
• Wydane: MDPI AG, 2024-08-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

[⁶⁸Ga]Ga-FAP-2286 is a new peptide-based radiopharmaceutical for positron-emission tomography (PET) that targets fibroblast activation protein (FAP). This article describes in detail the automated synthesis of [⁶⁸Ga]Ga-FAP-2286 using a commercially avail...